PNV.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 21:55):

Stats
Today's Volume	492 612
Average Volume	1.73M
Market Cap	1.45B
EPS	$0 ( 2024-02-26 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-210.00
ATR14	$0.00500 (0.24%)

Volume Correlation

Long: 0.07 (neutral)

Short: 0.33 (neutral)

Signal:(48.483) Neutral

Polynovo Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Polynovo Ltd Correlation - Currency/Commodity

-0.17
( neutral )

0.74
( moderate )

0.00
( neutral )

0.80
( moderate )

0.00
( neutral )

0.68
( moderate )

Polynovo Ltd Financials

Annual	2023
Revenue:	$65.24M
Gross Profit:	$19.33M (29.63 %)
EPS:	$-0.00720

Q2	2023
Revenue:	$47.15M
Gross Profit:	$16.60M (35.21 %)
EPS:	$0.00390

Q4	2023
Revenue:	$35.88M
Gross Profit:	$10.24M (28.54 %)
EPS:	$-0.00160

Q3	2022
Revenue:	$18.14M
Gross Profit:	$14.54M (80.12 %)
EPS:	$-0.000800

Financial Reports:

No articles found.

Polynovo Ltd

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.